AWARDED Top 'Optimal' Rating

The latest series of NordiQC test schemes produced impressive results with 8 antibodies from our collection.

NEW MARKER

MDM2 overexpression is associated with soft tissue sarcomas, osteosarcomas, and breast tumors.

AWARD

We are honoured to be the 13th Biggest Life Science Company in British Columbia in 2019 as listed by Business In Vancouver.